When No One Owns Material Decisions, Everyone Pays

Why shelf-life-constrained industries Life Sciences, regulated foods, specialty chemicals need a standardized, AI-driven decision layer their ERP was never built to provide.

In a rush? Here are the 3 key takeaways

👉 No one owns material decisions. Every function optimizes for its own KPI — planners forecast, buyers expedite, sales promotes, manufacturing scales batch sizes. Local optimization, global loss.

👉 In shelf-life-constrained industries, the bill is concrete: ~4% of pharma material is written off every year ($12.5B across 28 majors), 8–10% of hospital supply spend goes to expiry, ~2.9% of food inventory to spoilage.

👉 The fix isn't a new ERP. It's a decision-intelligence layer on top of the one you have, surfacing material risk live, drafting the recommended action, and routing it to the function that owns it.

In industries where material has a clock on it pharma APIs, biologics, vaccines, reagents, perishable foods, specialty chemicals time is the enemy. Every day a pallet sits in a warehouse, every forecast that misses, every purchase order that lands a week late each one quietly chips away at margin. The damage rarely announces itself. It accumulates.

But before you can fix that, there's a more basic question worth sitting with. And in most companies, it produces an uncomfortable silence.

Who actually owns material decisions?

Supply chain? Procurement? Planning? Manufacturing? Quality? Sales? Finance?

Ask seven leaders and you'll likely get seven answers, or seven careful deflections. The honest answer is that no one owns it. Material decisions are scattered across departments, systems, and a surprising number of spreadsheets. Everyone influences material. No single team controls it end to end.

That gap isn't a minor org-chart quirk. When ownership fragments, waste stops being an accident and becomes structural. The numbers make that uncomfortably concrete. In Life Sciences, the pharmaceutical industry writes off roughly 4% of material every year across 28 major pharma companies that worked out to $12.5 billion in a single benchmark year.¹ Downstream, expired and obsolete product accounts for an estimated 8–10% of supply spend at hospitals.² In regulated foods and CPG, the same dynamic shows up at a different magnitude: industry data puts annual food inventory loss to spoilage and overstock at around 2.9%, with adjacent personal-care categories writing off 6%+ to expiration and obsolescence.³ Specialty chemical operations carry their own version of the math shorter shelf lives, batch-specific certifications, temperature exposure and most of it never shows up cleanly on a P&L because it's bundled into "material impairment" or "obsolescence."

And the financial line is the easy part to talk about. In Life Sciences, the same fragmented decisions show up as patient risk stockouts on a therapy a hospital is counting on, expired material reaching a manufacturing line, batches lost to temperature excursions no one was watching. In regulated foods and chemicals, the equivalent is consumer safety, recalls, and lost shelf space. Across all of them: reputational and regulatory exposure FDA observations, audit findings, customer-imposed scorecards that no spreadsheet captures until it's already a problem.

How material reduction became everyone's job and no one's role

Material initiatives almost always start the same way: a directive from the top. Reduce working capital. Cut excess stock. Improve forecast accuracy. Bring down write-offs. Clear goals, reasonable goals.

Then they hit the operating floor, and ownership dissolves.

Planners adjust forecasts. Buyers delay POs. Sales pushes promotions to move volume. Manufacturing increases batch sizes because larger runs are more efficient. Quality holds material for re-test. Finance tracks material value on the balance sheet. Warehouse teams manage whatever is aging on the racks.

Every function is doing its job well. Every function is optimizing for its own KPI. And that's exactly the problem.

One team manufactures excess while another scrambles to liquidate it. One planner expedites material while a warehouse two states over sits on aging stock no one is looking at. This is how a company ends up carrying tens of millions in material and running stockouts at the same time. Not through incompetence through fragmentation. Local optimization, global loss.

What "standardizing material" actually means

Let's be precise, because this is where the idea usually gets misread. Standardizing material operations does not mean replacing your ERP. SAP, JDE, Oracle, Syspro they're fine at what they do. They record transactions.

What's missing on top of them is what we'd call an Material Decision Intelligence layer one that answers the questions that matter the same way, everywhere in the business:

Which SKUs and batches are at risk of expiry? Which materials are likely to stock out? Which material should move between plants? Which purchase orders should be delayed? Which finished goods need promotional or allocation action before they age out? Which forecasts are quietly driving overproduction? And critically who is responsible for acting on each of these?

Here's the part most leaders underestimate: the data to answer all of this usually already exists. What's missing isn't data. It's shared visibility, standardized workflows, prioritized recommendations, and clear accountability across teams. The raw material is already in the building. It's just inert.

From fragmented ownership to shared control

Modern material operations have to move past disconnected, opinion-driven decision-making. The answer isn't another spreadsheet, or a better-formatted version of last quarter's spreadsheet. It's operational coordination AI-driven recommendations paired with workflows that actually execute.

Static ERP reports tell you what happened. What operators need is a system that surfaces what's about to happen: excess material risk, stockout risk, aging stock, forecast deviations, supplier delays, demand variability, imbalances across plants and warehouses, batches drifting toward expiry windows.

And then it has to go one step further. It has to recommend the action:

Transfer 8,500 units from Plant A to Plant B. Delay the PO for Material M-445 — excess material on hand. Launch a targeted promotion for FG-789 before expiry risk climbs. Expedite the supplier shipment to keep the line running.

That shift from reporting on the past to recommending the next move is what turns material management from a reactive habit into a proactive operating discipline.

Why visibility changes behavior

When teams work from disconnected spreadsheets, decisions become a contest of opinions. The loudest forecast wins. The most urgent email gets answered first.

Make material risk visible across the enterprise and the dynamic changes. Sales starts to feel the real cost of an inaccurate forecast. Procurement sees the downstream weight of over-ordering. Manufacturing sees expiry exposure before it commits to the overproduction. Quality sees what's drifting toward release-or-reject limits. Executives see working-capital risk while there's still time to act on it.

Visibility creates accountability. Accountability builds operational discipline. And operational discipline is what steadily, unglamorously, drives waste and risk out of the system.

The standard is being set right now

Shelf-life-constrained industries are moving into a different operational era. Manual analysis, email-driven approvals, and disconnected ERP reports are no longer enough to manage material risk at the speed the business moves or at the standard regulators, customers, and patients now expect.

The companies that will lead the next decade aren't the ones with the most data or the newest ERP. They're the ones standardizing material operations now building shared workflows, cross-functional accountability, expiry-risk intelligence, real-time visibility, and AI-driven recommendations into how the business actually runs.

That's the layer Traceflow is built to be. It sits on top of the ERP you already have SAP, JDE, Oracle, Syspro and turns the transactional record underneath into a continuous read on material risk. Expiry windows, stockout exposure, aging stock, forecast deviation, supplier slippage, plant-to-plant imbalance: surfaced not as a monthly report, but as a live picture of what's about to break.

On top of that read, AI agents do the work most operators don't have time to do manually. They prioritize the risks that actually matter this week, draft the recommended action transfer, PO delay, reallocation, expedite, expiry-risk escalation and route it to the function that owns it with the context to act on it. The system proposes. The operator decides. The ERP executes. That's the decision layer that's been missing.

Because material was never just a supply chain problem. It's an enterprise decision system.

And when no one owns the decisions, everyone pays for them.

---

Sources

1. nVentic, Big Pharma material Benchmark 2023 (analyzing 2022 data across 28 companies). nventic.com/insights/pharma-inventory-trends-2023

2. BlueBin, Healthcare Supply Chain Waste Calculator industry average for product expiration on shelves. bluebin.com/resources/calculators/healthcare-supply-chain-waste-calculator

3. Spoiler Alert, The Hidden Costs of Excess material: Why CPG Brands Lose Millions Each Year. spoileralert.com/resources/the-hidden-costs-of-excess-inventory